BR0111292A - Composições com baixo teor de carboidrato, kits destas e métodos de uso - Google Patents

Composições com baixo teor de carboidrato, kits destas e métodos de uso

Info

Publication number
BR0111292A
BR0111292A BR0111292-9A BR0111292A BR0111292A BR 0111292 A BR0111292 A BR 0111292A BR 0111292 A BR0111292 A BR 0111292A BR 0111292 A BR0111292 A BR 0111292A
Authority
BR
Brazil
Prior art keywords
compositions
methylsulfonylmethane
present
low
kits
Prior art date
Application number
BR0111292-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Matthew Thomas Heisey
Kenneth Norman Kern
Kris Eugene Spence
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/759,965 external-priority patent/US20020132780A1/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0111292A publication Critical patent/BR0111292A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0111292-9A 2000-06-02 2001-06-01 Composições com baixo teor de carboidrato, kits destas e métodos de uso BR0111292A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
US09/759,965 US20020132780A1 (en) 2001-01-12 2001-01-12 Low carbohydrate compositions, kits thereof, and methods of use
PCT/US2001/017716 WO2001093831A2 (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use

Publications (1)

Publication Number Publication Date
BR0111292A true BR0111292A (pt) 2003-06-10

Family

ID=27079730

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111292-9A BR0111292A (pt) 2000-06-02 2001-06-01 Composições com baixo teor de carboidrato, kits destas e métodos de uso

Country Status (8)

Country Link
EP (1) EP1289532A2 (zh)
JP (1) JP2003535120A (zh)
CN (1) CN1438892A (zh)
AU (1) AU2001269730A1 (zh)
BR (1) BR0111292A (zh)
CA (1) CA2408610A1 (zh)
MX (1) MXPA02011939A (zh)
WO (1) WO2001093831A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431937B2 (en) * 2001-03-30 2008-10-07 L'oreal, S.A. Compositions comprising at least one aminated C5-C7 saccharide unit, and their use for the protection and/or repair of keratinous fibers
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
AU2003903037A0 (en) * 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
DK2526783T3 (en) * 2005-11-23 2017-02-06 Coca Cola Co Natural high-potency sweetener compositions with improved time profile and / or flavor profile
CA2732764C (en) * 2008-03-11 2023-04-04 Livionex Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
KR101314322B1 (ko) * 2009-09-28 2013-10-02 박유신 관절 및 결체조직 관련 질병의 치료 및 예방을 위한 약학 조성물
US9278112B2 (en) 2013-03-15 2016-03-08 New York University Citrate containing beverage
US20170027976A1 (en) * 2014-04-14 2017-02-02 Methylation Sciences International Srl Novel ademetionine formulations
JP6528588B2 (ja) * 2014-08-19 2019-06-12 大正製薬株式会社 固形製剤
KR101957502B1 (ko) * 2018-08-17 2019-03-12 이승훈 메틸설포닐메탄을 함유하는 비만, 지방간 및 당뇨병 예방 또는 개선용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
JP4070844B2 (ja) * 1997-08-20 2008-04-02 株式会社ヤクルト本社 マグネシウム含有経口組成物
JP2971855B1 (ja) * 1998-06-22 1999-11-08 明治乳業株式会社 風味のよいアミノ酸含有食品の製造方法
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
JP4300652B2 (ja) * 1998-09-21 2009-07-22 大正製薬株式会社 経口用固形製剤
US5993880A (en) * 1998-10-01 1999-11-30 Kraft Foods Inc. Non-staining, acid-stable, cold-water-soluble, edible green color and compositions for preparing acidic foods and beverages
JP2000175648A (ja) * 1998-12-11 2000-06-27 Sanei Gen Ffi Inc 乳清ミネラルを含有する甘味組成物
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
JP2000281562A (ja) * 1999-03-30 2000-10-10 Taisho Pharmaceut Co Ltd ゲル状組成物
JP2000290199A (ja) * 1999-03-31 2000-10-17 Taisho Pharmaceut Co Ltd 経口用医薬組成物
JP4173606B2 (ja) * 1999-06-18 2008-10-29 サントリー株式会社 低酸性飲料の製造方法

Also Published As

Publication number Publication date
CA2408610A1 (en) 2001-12-13
WO2001093831A2 (en) 2001-12-13
WO2001093831A3 (en) 2002-04-25
EP1289532A2 (en) 2003-03-12
MXPA02011939A (es) 2003-04-22
JP2003535120A (ja) 2003-11-25
CN1438892A (zh) 2003-08-27
AU2001269730A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
BR0111292A (pt) Composições com baixo teor de carboidrato, kits destas e métodos de uso
Pearson et al. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries.
Aasebø et al. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy
BR0110898A (pt) Composição anidra antiperspirante em bastão
BR112022010894A2 (pt) Composições orais úmidas
JP5339916B2 (ja) 骨関節炎の治療におけるａ３アデノシン受容体アゴニストの使用
BR0311939A (pt) composição farmacêutica, método para tratar inflamação em um mamìfero e uso de uma citocina protetora de tecido orgánico
BRPI0517434A (pt) composições farmacêuticas compreendendo antagonistas do receptor canabinóide cb1 e abridores de canal de potássio para o tratamento de diabetes mellitus do tipo i, obesidade e estados relacionados
Nguyen et al. Increase in urinary calcium and oxalate after fructose infusion
BR9809951A (pt) Método para tratamento da obesidade
KR960000923A (ko) 단량체성 인슐린 유사체의 제제
BRPI0311959B8 (pt) composição, métodos para preparar um polipeptídeo estável do fator vii, e para tratar uma síndrome responsiva do fator vii, e, uso do polipeptídeo do fator vii
AR060784A1 (es) Mezclas binarias de acido hialuronico y su uso terapeutico
TR199802394A2 (xx) Proteinleri stabilize etmek i�in geli�tirilmi� proses.
EA200001191A1 (ru) Новые фармацевтические композиции для лечения и жизнеобеспечения (поддержания жизненных функций) и способ их приготовления
AU2010212350B2 (en) Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
BR9808008A (pt) Processo para o tratamento anticoagulante e/ou antitrombótico de um ser humano ou outro paciente animal de sangue quente, usos de um oligossacarìdeo sulfatado e na fabricação de um medicamento, e, composição farmacêutica ou veterinária para tratamento anticoagulante e/ou antitrombótico.
BR9916845A (pt) Compostos de (aminoiminometil ouaminometil)benzo-heteroarila substituìdos
BRPI0411429A (pt) tratamento de sintomas associados com vaginose bacteriana
BR9811422A (pt) Processo para a inibição de hiperplasia celular de músculo liso vascular em um paciente humano ou em outro paciente animal de sangue quente necessitando de tal tratamento, uso de pelo menos um oligossacarìdeo sulfatado, e, composição farmacêutica ou veterinária para a inibição de hiperplasia celular de músculo liso vascular
KR890000093A (ko) 건선의 치료방법 및 치료용 조성물
Dahlin et al. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat
BRPI0416246A (pt) usos de pelo menos uma das histonas h2a, h2b, h3 ou h4, de um vetor e de anticorpos, composição farmacêutica e agente ou kit diagnóstico
Lochhead et al. Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury.
PT1058544E (pt) Inibicao da actividade do tnf

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SD IP HOLDINGS COMPANY (US)

Free format text: TRANSFERIDO DE: THE PROCTER AND GAMBLE COMPANY

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 11,13 E 25 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.